|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.95 USD | +10.44% |
|
+23.20% | +44.15% |
| Apr. 23 | BTIG Adjusts LifeMD's Price Target to $14 From $13, Keeps Buy Rating | MT |
| Mar. 12 | Craig-Hallum Adjusts LifeMD's Price Target to $15 From $10, Maintains Buy Rating | MT |
LifeMD, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 152.55 million compared to USD 119.03 million a year ago. Net loss was USD 20.6 million compared to USD 45.54 million a year ago.
Basic loss per share from continuing operations was USD 0.7 compared to USD 1.57 a year ago. Diluted loss per share from continuing operations was USD 0.7 compared to USD 1.57 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +44.15% | 482M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -0.13% | 893M | |
| -35.42% | 902M | |
| -24.12% | 857M |
LIFEMD, INC. 
